Jynarque
Ended Awarded Last action
- Contract number
- 36C26222F0417
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $282,855
Award facts
- Contract value 100% obligated
- $282,855.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Long Beach, CA 90822, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$14,396 | |
| Original award | $297,251 |
About this award
Otsuka America Pharmaceutical Inc. received a delivery order valued at $282,855.34 from the Department of Veterans Affairs' Veterans Integrated Service Network 22 for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. Issued on July 1, 2022, with a completion date of June 30, 2023, this firm fixed-price delivery order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carried no set-aside designation. The award reflects the VA's procurement of critical pharmaceutical treatments for veterans through its established contracting vehicles.
This delivery order is supported by Otsuka America Pharmaceutical Inc.'s substantial Indefinite Delivery Vehicle with the VA—an $83.3 million Blanket Purchase Agreement for Jynarque awarded by the National Acquisition Center that extends through March 26, 2026. The company's demonstrated capability to supply federal healthcare systems is further evidenced by its $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. These contracting relationships enable the VA to efficiently procure specialized pharmaceutical treatments across multiple Integrated Service Networks to support the Veterans Health Administration's mission of providing comprehensive healthcare services to veterans nationwide.
Quick answers
Who was awarded contract 36C26222F0417?
36C26222F0417 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on July 1, 2022.
How much is contract 36C26222F0417 worth?
The government has obligated $282,855 on 36C26222F0417.
Is contract 36C26222F0417 an order under another contract?
Yes. 36C26222F0417 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26222F0417 competed?
The extent of competition for 36C26222F0417 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award